Sex hormone-binding globulin as a biomarker for metabolic risk in European women with polycystic ovary syndrome

Sex hormone-binding globulin as a biomarker for metabolic risk in European women with polycystic ovary syndrome

Objective Sex hormone-binding globulin (SHBG) is suggested to be a biomarker for metabolic disturbances in women with polycystic ovary syndrome (PCOS). Insulin resistance and hyperinsulinemia is common in PCOS patients. Low SHBG increases free testosterone levels, which further induces hyperinsuline...

Full description

Saved in:
Bibliographic Details
Main Authors: Bo E. van Bree, Denise M. B. van der Heijden, Ron J. T. van Golde, Martijn C. G. J. Brouwers, Marc E. A. Spaanderman, Olivier Valkenburg
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Gynecological Endocrinology
Subjects:
Polycystic ovary syndrome (PCOS)
sex hormone-binding globulin (SHBG)
metabolic phenotype
metabolic syndrome
hyperandrogenism
Online Access:https://www.tandfonline.com/doi/10.1080/09513590.2025.2500462
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/09513590.2025.2500462

Similar Items